FN2 Earnings Intelligence
CVS Health Corp. income statement (quarterly)
CVS Health Corp. (CVS) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $10,076 | $11,787 | $9,098 | $9,542 | $11,329 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $94,588 | $98,915 | $102,871 | $100,426 | $106,096 | $104,493.6 | $106,789.3 |
| % Growth | - | - | - | - | - | 1.6% | - |
| Gross Profit | $43,531 | $44,910 | $45,826 | $44,982 | $47,234 | - | - |
| % Margin | 46.0% | 45.4% | 44.5% | 44.8% | 44.5% | - | - |
| EBITDA | $4,528 | $3,552 | -$2,073 | $5,795 | $5,829 | - | - |
| % Margin | 4.8% | 3.6% | -2.0% | 5.8% | 5.5% | - | - |
| Net Income | $1,779 | $1,021 | -$3,975 | $2,943 | $2,979 | - | - |
| % Margin | 1.9% | 1.0% | -3.9% | 2.9% | 2.8% | - | - |
| Diluted EPS | $1.41 | $0.80 | -$3.13 | $2.30 | $2.31 | $1.63 | $1.28 |
| % Growth | - | - | - | - | - | 152.2% | - |
| Operating Cash Flow | $4,556 | - | - | $4,249 | - | - | - |
| CapEx | $743 | - | - | $849 | - | - | - |
| Free Cash Flow | $3,813 | - | - | $3,400 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $94,588 | $98,915 | $102,871 | $100,426 | $106,096 | $104,493.6 | $106,789.3 |
| Gross Profit | $43,531 | $44,910 | $45,826 | $44,982 | $47,234 | - | - |
| EBITDA | $4,528 | $3,552 | -$2,073 | $5,795 | $5,829 | - | - |
| Net Income | $1,779 | $1,021 | -$3,975 | $2,943 | $2,979 | - | - |
| Diluted EPS | $1.41 | $0.80 | -$3.13 | $2.30 | $2.31 | $1.63 | $1.28 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $10,076 | $11,787 | $9,098 | $9,542 | $11,329 |
| Short-term Debt | $1,259 | $3,040 | $1,247 | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4,556 | - | - | $4,249 | - |
| Capital Expenditure | $743 | - | - | $849 | - |
| Free Cash Flow | $3,813 | - | - | $3,400 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 46.0% | 45.4% | 44.5% | 44.8% | 44.5% |
| EBITDA Margin | 4.8% | 3.6% | -2.0% | 5.8% | 5.5% |
| Net Margin | 1.9% | 1.0% | -3.9% | 2.9% | 2.8% |
| FCF Margin | 4.0% | - | - | 3.4% | - |
| Diluted EPS Growth | - | - | - | - | - |